ADVERTISEMENT
Close
In This Issue, Subscribe, Free Issue, Contact Us
ADVERTISEMENT
 
Treatments > Drug Guide > Recalls and Alerts
Print Email

Recalls and Alerts

Stay informed on the latest FDA recalls and alerts, shortages, market withdrawals and changes in label warnings for drugs and devices commonly used to treat arthritis.

Methotrexate Shortage Has Many With Arthritis Concerned, Too
Rheumatoid arthritis and juvenile arthritis patients who can’t tolerate oral methotrexate most vulnerable 2/17/12

Health Advisory Issued for Certain Painkillers
Manufacturing mishap may cause mix-ups and shortage of some opiate analgesics 1/19/12

Novartis Recalls Excedrin and Bufferin Products
Manufacturing problems may cause product mix-ups or improper dose 1/19/12

FDA Adds New Anti-TNF Infection Warnings
Two types of bacteria pose infection risks for those taking the biologics. 9/8/11

FDA Strengthens Anti-TNF Warnings
Two types of bacteria pose infection risks for those taking the biologics 9/8/11

Tylenol 8-Hour Caplets Recalled
Another batch is pulled from the market due to a musty odor 3/31/11

Simponi Injectible Pens Recalled
Some injection devices for this biologic medicine are found defective, but many, maybe all, have not yet reached consumers. 2/22/11

Popular Painkillers Darvocet, Darvon Pulled from Shelves
The Food and Drug Administration cites new evidence these opioid drugs can cause potentially fatal heart problems. 12/8/10

Injectable Methotrexate Recalled
Some vials of the drug, a mainstay of rheumatoid arthritis treatment, are tainted, posing a risk to users. 10/28/10

More Tylenol Recalled
Tylenol recalled of a moldy odor that has been linked to consumer complaints of nausea and vomiting. 10/19/10

The FDA Says It Mistakenly Approved the Menaflex Knee Device
The FDA is now rescinding its approval of the Menaflex Collagen Scaffold. 10/14/10

Two Hip Replacement Implants Recalled
About 1 in 8 people with ASR components has needed corrective surgery within five years. 8/26/10

FDA Upgrades Warning for an Arthritis Drug
Rare, but severe, liver injuries seen with leflunomide (Arava). 7/14/10

Tylenol Recall Expanded
After a rebuke by federal regulators for its slow response to consumer complaints, Johnson & Johnson has expanded its original recall of over-the-counter products. 1/15/10

Tylenol Arthritis Pain Caplets Recalled
Federal officials have announced an expanded recall of Tylenol Arthritis Pain Caplets in 100-count bottles. 12/30/09

New Warnings for an Arthritis Pain Reliever
FDA adds risk of liver damage to labels of anti-inflammatories containing diclofenac. 12/15/09

Arthritis Drug May Confuse Glucose Meters
Orencia and dialysis solution can cause false blood sugar readings. 9/9/09

New Warnings Ordered for Kids' Arthritis Medications
FDA orders stronger warnings for some biologic drugs used to treat juvenile arthritis after evidence reveals increased cancer risks in children. 8/04/09

Psoriasis Medication Taken Off the Market
Biologic drug Raptiva withdrawn due to risk of rare brain disorder. 4/09/09

Fibromyalgia Drug Warnings
FDA warns of suicide risk for 3 fibro drugs and 20 other medications. 1/15/09

Arthritis Drugs Linked to Infection Risk
FDA calls for stronger warning of fungal infection on TNF blockers. 9/4/08

Stronger Warning of Tuberculosis Risk in Enbrel
FDA requires boxed warning highlighting need for screening and ongoing monitoring for TB. 3/18/08

Fentanyl Pain Patches Recalled
After tests revealed too-rapid release of active ingredient about one million fentanyl patches for chronic pain have been recalled from store and pharmacy shelves. 2/13/08

ADVERTISEMENT
Arthritis Foundation National Health Council BBB Accredited Charity